Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Filament Health Corp
N.FH
Alternate Symbol(s):
FLHLF
Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of psilocybe cubensis fruiting bodies include: PEX010 Psilocybin ...
- oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:FH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
fossil8
X
View Profile
View Bullboard History
Post by
fossil8
on Jan 02, 2024 6:48pm
Deal
I am one happy camper that this deal did not go through. It was bad from the get go. What has not been reported is what the cost was to walk away and WHY was it terminated. Filament is bleeding
...more
(1867)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Sep 27, 2023 11:19am
Jupiter redemptions
Jupiter had $160 million cash at March 31, 2023 and $15 million at June 30, 2023
Viva Gold: Multiple High-Grade Gold Hits Includes 90 Meters at 2.0 gpt Gold
posted May 05, 2024 9:00am by
Viva Gold Corp.
-
|
TG2409 (21.3 meters at 5.1 gpt Au) was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40 meters depth). TG2408 (18.3 meters at 4.4 gpt Au). TG2407 (89.9 meters@ 2.0 gpt Au). TG2404 (36.6 Meters @ 3.3 gpt Au). “Many geologists go their whole careers without seeing drill results like these ...read more
(1867)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 15, 2023 11:23am
RE:1-for-10 rollback
Jupiter has $217 mil Cdn cash & securities but assuming 90% redemptions and $13.3 mil transaction costs so only $7 mil cdn cash after RTO and total of 29.3 mil shs o/s
(1867)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 15, 2023 11:01am
1-for-10 rollback
Filament shareholders only get 20,600,000 shares in merged co. This is 1/10 of FH shares o/s. https://www.sec.gov/Archives/edgar/data/1988363/000121390023067070/ff42023
...more
(0)
•••
fossil8
X
View Profile
View Bullboard History
Post by
fossil8
on Aug 08, 2023 7:27pm
Patience Required
This stock is going to rock especially with the new alliance. Doors will open now and funds will be available. Got a dream team running it. We will all have to be patient but it is a
...more
(1864)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jun 30, 2023 8:09am
FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT
NeoLumina's license for Filament's botanical psilocybin drug candidate provides exclusive global right to clinical and commercial development for eating disorders VANCOUVER, BC, June 30
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Post by
Firepoker
on Apr 26, 2023 8:09am
2023 Spring Event and Media Appearances
https://www.filament.health/news/filament-health-announces-spring-2023-event-and-media-appearances
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Post by
Firepoker
on Apr 26, 2023 8:04am
Filament TV interview on CTV today...excellent exposure for
CTV your morning at 8:10am eastern 5:10 pacific MEDIA -On Wednesday, April 26, at 8:10 a.m. ET, Mr. Lightburn will appear on CTV’s Your Morning to discuss the Company’s recent development of GMP MDMA
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Post by
Firepoker
on Apr 22, 2023 6:55am
Great Partnership
https://mugglehead.com/pharmala-biotech-and-filament-health-partner-to-release-mdma-capsules/
(4)
•••
CmMuskie
X
View Profile
View Bullboard History
Post by
CmMuskie
on Aug 18, 2022 5:03pm
Eight paten issued!
https://www.newswire.ca/news-releases/filament-health-announces-eighth-patent-issuance-888386340.html
(4)
•••
CmMuskie
X
View Profile
View Bullboard History
Post by
CmMuskie
on Aug 16, 2022 3:41pm
Worth noting. Insiders own about 70% of the shares.
Insider Transactions Reported - Last Two Years Insider Transaction Type Value Date Shares LIGHTBURN (BENJAMIN
...more
(2)
•••
younginvestor27
X
View Profile
View Bullboard History
Comment by
younginvestor27
on Apr 16, 2022 5:17pm
RE:Hi
is it me your looking for
(19)
•••
SHeditorial
X
View Profile
View Bullboard History
Post by
SHeditorial
on Apr 13, 2022 11:52am
Safe, Natural Psychedelics play worth watching
https://stockhouse.com/opinion/interviews/2022/04/12/unlocking-healing-potential-safe-natural-psychedelics
(1864)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jan 31, 2022 3:53pm
APPROVAL FOR PHASE II CLINICAL TRIAL FOR DEPRESSION
Trial to investigate the effects of Filament's botanical psilocybin drug candidate and Cybin Therapeutics' protocols in treating major depressive disorder in patients taking SSRIs. Patient
...more
(1864)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 03, 2021 2:58pm
The Power Play by The Market Herald Releases New Interviews
Filament Health has received FDA authorization to initiate the first clinical trial using naturally sourced psychedelic substances. The phase 1 trial will include 20 healthy subjects and examine the
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test